文献速递腹部MR

基于感兴趣区与容积测量在MR弹性成像量化肝脏硬度异质性中的比较

Comparison between ROI-based and volumetric measurements in quantifying heterogeneity of liver stiffness using MR elastography.
PubMed 文献 · Eur Radiol · 2019-11-08

本研究通过比较基于感兴趣区(ROI)与容积分割测量肝脏硬度(LS)的方法,量化MR弹性成像(MRE)上的LS异质性。纳入128例疑似肝纤维化患者,ROI法平均LS为2.7±1.0 kPa,容积法为2.6±0.9 kPa(p=0.001)。59例F0期患者中31例(52.5%)有超过20%肝体积LS异常,18例(14%)存在异质性。结论认为平均LS测量可能不能代表全部肝纤维化谱,容积分割可能提高异质性纤维化检测和LS测量准确性。

要点

  • ROI法与容积法测得的平均肝脏硬度分别为2.7±1.0 kPa与2.6±0.9 kPa,差异有统计学意义(p=0.001)。
  • 59例F0期患者中31例(52.5%)有超过20%肝体积存在异常硬度(F1-F4),提示ROI平均法可能漏诊异质性纤维化。
  • 18例(14%)患者存在肝脏硬度异质性,即最主要与次主要纤维化分期相差超过一个类别。

核心结论

  • 平均肝脏硬度测量可能不能代表整个肝纤维化谱,容积分割可能有助于检测异质性纤维化并提高LS测量准确性。

研究设计与样本

  • 研究纳入128例疑似肝纤维化患者(平均年龄54.4±14.8岁),采用ROI法和容积分割法测量肝脏硬度,以平均LS值进行纤维化分期;比较两种方法的平均LS值使用Wilcoxon符号秩检验。

关键影像表现/征象

  • 基于ROI和容积分割测量肝脏硬度,平均LS分别为2.7±1.0 kPa和2.6±0.9 kPa(p=0.001)。
  • 59例F0期患者中31例(52.5%)有超过20%的肝脏体积表现为异常LS(F1-F4)。
  • 18例(14%)患者报告存在肝脏硬度异质性,定义为最主要和次主要纤维化分期相差超过一个类别。

诊断标准与关键数值

  • 肝脏硬度异质性定义为最主要和次主要纤维化分期相差超过一个类别。
  • ROI法平均LS为2.7±1.0 kPa,容积法平均LS为2.6±0.9 kPa(p=0.001)。
  • 59例F0期患者中31例(52.5%)有超过20%肝体积LS异常(F1-F4)。

临床应用与阅片要点

  • ROI法测量平均肝脏硬度并报告均值可能无法检测肝纤维化的异质性。
  • 采用MR弹性成像的容积评估可能检测肝实质受累的异质性。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: This study was conducted to quantify the heterogeneity of liver stiffness (LS) on MR elastography (MRE) by comparing ROI-based and volumetric measurements.

METHODS: LS was measured by ROI-based and volumetric segmentation of the liver parenchyma. Mean LS (MLS) was calculated and used to assign stages of fibrosis. Volumetric measurements of stiffness maps were used to determine the percentage of liver volume above/below MLS and presence of LS heterogeneity. Heterogeneous stiffness was defined when the first and second most predominant stages were more than one category apart. MLS values by each method were compared using the Wilcoxon signed-rank test.

RESULTS: We included 128 patients with suspected liver fibrosis (mean age 54.4 ± 14.8 years). MLS was 2.7 ± 1.0 kPa for ROI measurements and 2.6 ± 0.9 kPa for the volumetric method (p = 0.001). Of 59 patients with normal stage (F0), 31 patients (52.5%) had > 20% of liver volume with abnormal LS (F1-F4). Heterogeneous LS was reported in 18 patients (14%).

CONCLUSIONS: MLS measurement may not represent the entire spectrum of hepatic fibrosis. Volumetric segmentation may potentially improve the detection of heterogeneous fibrosis and the accuracy of LS measurement.

KEY POINTS: • Heterogeneity of hepatic fibrosis may occur in patients with chronic liver disease. • MR elastography is used to assess hepatic fibrosis by measuring liver stiffness. • Measuring liver stiffness by the ROI method and reporting a mean value may fail to detect heterogeneity of hepatic fibrosis. Volumetric assessment of liver stiffness by MR elastography may detect heterogeneity of parenchymal involvement.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Rezvani Habibabadi R, Khoshpouri P, Ghadimi M, et al. Comparison between ROI-based and volumetric measurements in quantifying heterogeneity of liver stiffness using MR elastography. Eur Radiol. 2019. PMID: 31705257. doi:10.1007/s00330-019-06478-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。